Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Canton, GA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Canton, GA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Decatur, GA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lexington, KY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rockville, MD
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Belmont, MA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Belmont, MA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Traverse City, MI
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Traverse City, MI
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Creve Coeur, MO
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Albuquerque, NM
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Amherst, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Amherst, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Latham, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Latham, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Staten Island, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Beachwood, OH
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Beachwood, OH
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Toledo, OH
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Eugene, OR
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Eugene, OR
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
East Providence, RI
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
East Providence, RI
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Greer, SC
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sioux Falls, SD
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bennington, VT
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bennington, VT
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Burlington, VT
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
mi
from
Buenos Aires,
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
mi
from
Buenos Aires,
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172
BAY 94-9172 PET/CT in Cognitively Normal Older Adults, Older Adults With Mild Cognitive Impairment, and Older Adults With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172
BAY 94-9172 PET/CT in Cognitively Normal Older Adults, Older Adults With Mild Cognitive Impairment, and Older Adults With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Banner Sun Health Research Institute
mi
from
Sun City, AZ
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Banner Sun Health Research Institute
mi
from
Sun City, AZ
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine
mi
from
Irvine, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California, Davis
mi
from
Martinez, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California, Davis
mi
from
Martinez, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine (Brain Imaging Center)
mi
from
Orange, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine (Brain Imaging Center)
mi
from
Orange, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Stanford University / PAIRE
mi
from
Palo Alto, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Stanford University / PAIRE
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Wien Center for Clinical Research
mi
from
Miami Beach, FL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Wien Center for Clinical Research
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Premiere Research Institute
mi
from
West Palm Beach, FL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Premiere Research Institute
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials